◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items

迈克生物

迈克生物
Loading...
Price History
Market Data
Market Cap6.7B
Market Cap (USD)$927.4M
P/E Ratio-
P/B Ratio-
EPS0.21
Dividend Yield-
D/E Ratio0.24
Current Ratio3.04
Market SegmentChiNext
CurrencyCNY
Business Overview

Maccura Biotechnology Co.Ltd engages in the research, development, manufacture, and sale of in vitro diagnostic products; and provides related services for medical laboratories in China and internationally. The company offers laboratory automation solutions, such as hematology analysis workstations; immunoassay products, such as chemiluminescence analyzers and reagents; molecular products, such as digital PCR and extraction systems, and PCR kits; urinalysis analyzer systems and semi-automatic urine analyzers; and hemostasis solutions, including coagulation and semi-automatic coagulation analyzers. It provides clinical chemistry products, such as glycohemoglobin and protein analyzer, biochemistry systems, and chemistry regents; blood group product solutions; and pathology solutions, such as a liquid-based cytology processing system. Maccura Biotechnology Co.Ltd was founded in 1994 and is headquartered in Chengdu, China.

证监会行业分类 C27医药制造业 SZSE
Key Financial Metrics
2.5B
Revenue
119.0M
Net Income
0.21
EPS (Diluted)
-329.0M
Free Cash Flow
Profitability
Gross Margin -
Operating Margin 6.7%
Net Profit Margin 4.7%
EBITDA 170.0M
Returns & Efficiency
Return on Assets (ROA) 1.5%
Return on Equity (ROE) 1.9%
Dividend Yield -
EPS 0.21
Financial Health
Total Assets 8.0B
Total Debt 1.6B
Debt to Equity 0.24x
Current Ratio 3.04
Company Info
IndustryC27医药制造业
Market SegmentChiNext
CurrencyCNY
Fiscal Year2024
Peers
2.7T
P/E: 7.6
2.5T
P/E: 7.2
2.4T
P/E: 8.7
CNOOC LIMITED
600938
2.0T
P/E: 16.2
1.9T
P/E: 25.6
1.8T
P/E: 20.1
1.8T
P/E: 7.3
1.2T
P/E: 6.9
Stock Chart
Open Full Chart View

Full charting with technical indicators, candlestick, line charts, and more.

Company Profile
General Information
Company Name迈克生物
Ticker300463
ExchangeSZSE
Sector证监会行业分类
IndustryC27医药制造业
Market SegmentChiNext
Fiscal Year2024
CurrencyCNY
Financial Summary
Market Cap6.7B
Market Cap (USD)$927.4M
Revenue2.5B
Net Income119.0M
P/E Ratio-
EPS0.21
Net Margin4.7%
ROE1.9%
Dividend Yield-
Description

Maccura Biotechnology Co.Ltd engages in the research, development, manufacture, and sale of in vitro diagnostic products; and provides related services for medical laboratories in China and internationally. The company offers laboratory automation solutions, such as hematology analysis workstations; immunoassay products, such as chemiluminescence analyzers and reagents; molecular products, such as digital PCR and extraction systems, and PCR kits; urinalysis analyzer systems and semi-automatic urine analyzers; and hemostasis solutions, including coagulation and semi-automatic coagulation analyzers. It provides clinical chemistry products, such as glycohemoglobin and protein analyzer, biochemistry systems, and chemistry regents; blood group product solutions; and pathology solutions, such as a liquid-based cytology processing system. Maccura Biotechnology Co.Ltd was founded in 1994 and is headquartered in Chengdu, China.

NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...